Method for culturing mammalian cells

By culturing mammalian cells, particularly PBMCs, in Ringer's solution medium under a low CO2 atmosphere, the cost and control challenges of culturing under a high CO2 atmosphere have been overcome. This has resulted in a stable pH environment and highly efficient cell culture, making it suitable for the treatment and prevention of various diseases.

CN123076673APending Publication Date: 2026-11-10APOSTAIS AG
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202580026235.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-04-03
Filing Date
2025-04-03
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Using a CO2-rich atmosphere in mammalian cell culture is costly, challenging to control, and unsuitable for pH regulation in certain cell types, particularly peripheral blood mononuclear cell (PBMC) culture, where current technologies struggle to maintain a suitable pH environment without relying on CO2.

Method used

Using Ringer's solution as the culture medium, mammalian cells, especially PBMCs, are incubated or cultured in an atmosphere containing less than 1% carbon dioxide. The components of Ringer's solution, such as sodium, potassium, calcium ions, lactate, albumin, and insulin, are used to maintain the stability of the cell growth environment and pH balance.

Benefits of technology

This method enables efficient PBMC culture under a low CO2 atmosphere, reducing reliance on CO2 incubators, lowering culture costs, and achieving cell culture results similar to those under a high CO2 atmosphere, especially in terms of the bioactivity of PBMC supernatant, making it suitable for the treatment and prevention of various diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The invention relates to a method for culturing peripheral blood mononuclear cells (PBMCs) comprising the step of incubating the cells in Ringer's solution under an atmosphere comprising less than 1% carbon dioxide.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of mammalian cell culture. Background Technology

[0002] Mammalian cells are typically cultured in cell culture media in the presence of an atmosphere containing carbon dioxide (CO2). Carbon dioxide helps maintain the pH of the medium within a range suitable for mammalian cells. When CO2 dissolves in the medium, it forms carbonic acid, which acts as a buffer and helps prevent the medium from becoming too acidic or too alkaline. CO2 also plays a role in regulating the osmolar concentration of the medium, ensuring that the cells are in an optimal environment. A typical CO2 concentration for culturing mammalian cells is approximately 5%. This level is designed to maintain pH balance in the medium and promote optimal cell metabolism through bicarbonate buffering. However, there are some drawbacks to using a CO2-containing atmosphere during mammalian cell culture.

[0003] The need for a controlled CO2 supply (typically via a CO2 incubator) increases the overall cost of mammalian cell culture. Stable CO2 levels must be ensured because concentration fluctuations or exposure to air during medium changes can negatively impact mammalian cells. In particular, mammalian cells are sensitive to pH changes, and CO2-driven pH regulation may not provide optimal conditions for all cell types. Some cell lines may require specialized conditions or alternative methods for pH regulation. For example, peripheral blood mononuclear cells (PBMCs) are typically cultured in an atmosphere containing 5% CO2 (see, for example, Beer L et al., Apoptosis, 21(2016):1336-1353).

[0004] Overall, while CO2 is often used to culture mammalian cells due to its pH-regulating and carbon source properties, its cost, control challenges, and potential limitations for certain cell types should be considered when designing cell culture methods.

[0005] Chen J et al. (ASTROBIOLOGY 13(2013): 370-379) disclosed a culture medium suitable for culturing stem cells in a CO2-independent manner. Stem cells cultured in this medium under CO2-independent conditions showed similar proliferation potential to those cultured in conventional media under CO2-dependent conditions.

[0006] Rampoldi A et al. (BIOMATERIALS 269(2021): 120673) described the culture of stem cell-derived cardiac progenitor cells in cell culture media suitable for growth, differentiation, and cryopreservation under CO2-independent conditions.

[0007] Therefore, the object of the present invention is to provide a method for culturing mammalian cells, particularly peripheral blood mononuclear cells (PBMCs), which overcomes the disadvantages of using a CO2-rich atmosphere. Summary of the Invention

[0008] This invention relates to a method for culturing peripheral blood mononuclear cells (PBMCs), comprising the step of incubating or culturing the cells in Ringer's solution under an atmosphere containing less than 1% carbon dioxide.

[0009] Surprisingly, it was found that using Ringer's solution as the cell culture medium, PBMCs and general mammalian cells could be cultured in an atmosphere containing less than 1% CO2. It was also found that using Ringer's solution allowed the pH to be maintained within a range suitable for PBMCs and other mammalian cells, even though the CO2 concentration in the cell culture atmosphere was low compared to commonly used atmospheres / gases containing 4% to 7% or about 5% CO2. This is particularly advantageous because it eliminates the need for CO2 incubators typically used for culturing mammalian cells; even air (i.e., atmospheric air) can be used to culture mammalian cells without the addition of additional CO2.

[0010] Another aspect of the invention relates to a method for obtaining a supernatant of peripheral blood mononuclear cell (PBMC) cells, preferably human PBMCs, comprising culturing the cells in a Ringer's solution as a culture medium under an atmosphere containing less than 1% carbon dioxide, and separating the supernatant by removing the cells. Attached Figure Description

[0011] Figure 1 The enhanced potency of the supernatant, measured by Hsp27 phosphorylation, is shown when cultured at low CO2 concentrations.

[0012] Figure 2 The enhanced but comparable potency of the supernatant, measured by AP1 activation, is shown when cultured in fresh medium with low CO2 concentration.

[0013] Figure 3 The comparable concentrations of EGF in the supernatant after culturing with existing medium at 5% CO2 or with new medium at a lower CO2 concentration are shown.

[0014] Figure 4 The comparable concentrations of TGF β1 in the supernatant after culturing with existing medium at 5% CO2 or with new medium at a lower CO2 concentration are shown.

[0015] Figure 5This demonstrates the comparability of cell budding induction in mouse aortic tissue between the supernatant obtained from culturing in existing medium at 5% CO2 and the supernatant obtained from culturing in new medium at a lower CO2 concentration. Detailed Implementation

[0016] According to the invention, the atmosphere is formed by adding a gas to a container (e.g., a bioreactor) containing Ringer's solution and PBMC. The gas may be located in the headspace of the container or added to the headspace of the container, and / or added via a venting device preferably positioned in the container, preferably in the bioreactor.

[0017] According to a preferred embodiment of the invention, the atmosphere contains less than 0.5%, preferably less than 0.2%, more preferably less than 0.1%, and even more preferably less than 0.05% carbon dioxide.

[0018] According to another preferred embodiment of the invention, the atmosphere comprises oxygen and / or nitrogen.

[0019] The atmosphere in which PBMCs are incubated and cultured preferably also contains oxygen, preferably 0.5% to 21%, more preferably 1% to 21%, even more preferably 5% to 21%, and even more preferably 10% to 21% oxygen. The atmosphere may also contain nitrogen, preferably 60% to 78%, more preferably 65% ​​to 78%, and even more preferably 70% to 78% nitrogen. In a particularly preferred embodiment of the invention, the atmosphere is air.

[0020] To prevent contamination of cell cultures, sterilized gas or air is preferably used to obtain the atmosphere. Methods for preparing the atmosphere used in cell culture methods are well known to those skilled in the art and may include filtration, UV sterilization, and ozone treatment, wherein physical methods, such as filtration, are preferred to avoid any residues that may be harmful to the cells to be cultured. For example, filtration involves passing air through a filter capable of trapping bacteria and viruses. UV sterilization uses ultraviolet light to kill microorganisms. Ozone treatment involves using ozone gas to disinfect the air.

[0021] The Ringer's solution may contain 50 to 200 mmol / L, preferably 100 to 150 mmol / L, more preferably 125 to 135 mmol / L, more preferably 130 to 132 mmol / L, and more preferably about 131 mmol / L of sodium ions.

[0022] As used herein, “about” means that the concentration associated with the term may be 10% higher or lower, preferably 5% higher or lower, more preferably 4% higher or lower, more preferably 3% higher or lower, more preferably 2% higher or lower, and more preferably 1% higher or lower.

[0023] At least one sodium salt may be sodium chloride.

[0024] The Ringer's solution may contain 2 to 8 mmol / L, preferably 3 to 6 mmol / L, more preferably 4 to 6 mmol / L, more preferably 5 to 6 mmol / L, and more preferably about 5.36 mmol / L of potassium ions.

[0025] At least one potassium salt may be potassium chloride.

[0026] The Ringer's solution may contain 0.5 to 3 mmol / L, preferably 1 to 2 mmol / L, more preferably 1.5 to 2 mmol / L, and even more preferably about 1.84 mmol / L of calcium ions.

[0027] At least one calcium salt can be calcium chloride.

[0028] The culture medium used for culturing mammalian cells is or contains Ringer's solution (USP43-NF38 (2020), monograph "Ringer's Injection", page 3887).

[0029] According to another preferred embodiment of the invention, the Ringer's solution further comprises at least one C2 to C5 carboxylate, wherein the C2 to C5 carboxylate is preferably a lactate, more preferably an L-lactate.

[0030] Adding one or more carboxylic acids or their salts to Ringer's solution serves multiple purposes. Carboxylic acids or their salts can be metabolized by mammalian cells during culture as an energy source. They can act as buffers, helping to maintain the pH of the culture medium within the physiological range. They help stabilize pH and prevent it from becoming too acidic or too alkaline by acting as a weak acid / weak base reservoir. Carboxylic acids or their salts help maintain electrolyte balance in solution. They are often included in Ringer's solution to prevent instability of sodium, potassium, and chloride ion levels. In general, carboxylic acids or their salts, especially lactates, in culture media play an important role in providing energy, maintaining pH balance, and ensuring electrolyte stability in vivo.

[0031] In a preferred embodiment of the invention, the Ringer's solution contains at least one C2 to C5 carboxylate at a concentration of 10 to 50 mmol / L, preferably 15 to 40 mmol / L, more preferably 20 to 30 mmol / L, and more preferably about 28 mmol / L, preferably at least one lactate.

[0032] According to a preferred embodiment of the invention, at least one C2 to C5 carboxylate is an alkali metal salt or an alkaline earth metal salt, preferably a sodium salt. Thus, in a particularly preferred embodiment of the invention, the culture medium is a lactated Ringer's solution (USP43-NF38 (2020), monograph "Lactated Ringer's Injection", S.3891).

[0033] According to another preferred embodiment of the invention, the Ringer's solution contains at least one polypeptide, preferably at least one blood polypeptide.

[0034] According to a preferred embodiment of the present invention, at least one polypeptide is selected from albumin (preferably serum albumin) and insulin.

[0035] According to another preferred embodiment of the invention, the Ringer's solution contains albumin (preferably serum albumin) and / or insulin.

[0036] The polypeptides (such as albumin) in the Ringer's solution of the present invention can act as colloidal permeabilizers. Albumin is a protein found in blood plasma that helps maintain fluid balance in the body by exerting osmotic pressure to prevent fluid from leaking out of blood vessels. When added to a culture medium, albumin helps maintain proper fluid balance.

[0037] The presence of insulin in the Ringer's solution of this invention can also be beneficial. Insulin can affect the growth and maintenance of cells in vitro. It is known that insulin binds to insulin receptors on the cell surface, triggering a cascade of signaling pathways that regulate cell growth and survival. These signaling pathways can influence the control of cell cycle progression, protein synthesis, and other cellular processes.

[0038] According to another preferred embodiment of the invention, the Ringer's solution contains at least one polypeptide of 1 mg / L to 50 g / L, preferably 2 mg / L to 40 g / L, more preferably 4 mg / L to 30 g / L, more preferably 1 g / L to 20 g / L, and more preferably 2 g / L to 10 g / L.

[0039] According to a preferred embodiment of the invention, the Ringer's solution contains 1 to 50 g / L, preferably 2 to 40 g / L, more preferably 4 to 30 g / L, more preferably 5 to 20 g / L, more preferably 6 to 10 g / L of albumin, preferably serum albumin.

[0040] According to another preferred embodiment of the invention, the Ringer's solution contains 1 to 20 mg / L, preferably 2 to 15 mg / L, more preferably 3 to 10 mg / L, and even more preferably 4 to 6 mg / L of insulin.

[0041] According to a preferred embodiment of the invention, the pH of the Ringer's solution is 5 to 7.

[0042] According to another preferred embodiment, the cells are incubated / cultured in the Ringer's solution of the present invention at a temperature of 30°C to 38°C, preferably 35°C to 38°C.

[0043] According to a particularly preferred embodiment of the invention, the peripheral blood mononuclear cells (PBMCs) preferably include monocytes, T cells, B cells and / or NK cells.

[0044] The method of the present invention is particularly suitable for culturing PBMCs, preferably PBMCs subjected to stress, and more preferably irradiated PBMCs.

[0045] Cells, particularly mammalian cells, are known to secrete large amounts of substances into the cell culture medium during culture. The conditioned media thus obtained can be used for the treatment and / or prevention of various diseases and conditions. For example, WO 2010 / 070105 and WO2010 / 079086 disclose conditioned media (“supernatants”) obtained by culturing PBMCs and used for the treatment of various inflammatory conditions. Therefore, the method of the present invention is preferably used to obtain a supernatant of a PBMC cell culture, wherein the cells are cultured in the Ringer's solution of the present invention. After the culture step, the cultured PBMCs are removed from the culture medium to obtain a substantially cell-free, preferably completely cell-free, supernatant. The supernatant of the PBMC culture contains, in addition to the components of the culture medium, substances produced and secreted by the PBMCs and / or even lysed PBMCs. The “supernatant” can be used interchangeably with the conditioned media or secretory groups available by culturing PBMCs.

[0046] The method of the present invention involves the use of a Ringer's solution, which preferably contains only compounds that can be administered intravenously, for example, to a mammal (preferably a human) subject. Therefore, in a preferred embodiment of the invention, the Ringer's solution does not contain compounds that would prevent the supernatant from being administered intravenously to a mammal (preferably a human) subject. The Ringer's solution is used as a culture medium, which may contain additional proteins as described above, such as albumin and / or insulin.

[0047] Before and / or during culturing PBMCs in the Ringer's solution of the present invention, the cells are preferably subjected to ionizing radiation. In addition to these stress-inducing conditions, the PBMCs may also be subjected to further stress. Therefore, according to a preferred embodiment of the invention, the PBMCs are subjected to one or more further stress-inducing conditions before or during culturing. Conditions that induce cellular stress include heat, chemicals, radiation, hypoxia, osmotic pressure, etc.

[0048] According to a preferred embodiment of the invention, the stress-inducing conditions include hypoxia, ozone, heat (e.g., more than 2°C, preferably more than 5°C, more preferably more than 10°C above the optimal culture temperature of PBMCs (i.e., 37°C), radiation (e.g., UV radiation), chemicals, osmotic pressure (i.e., osmotic conditions that are at least 10% higher than those that are normally present in body fluids, especially blood) or combinations thereof.

[0049] According to another preferred embodiment of the invention, the PBMC is subjected to ionizing radiation doses of at least 10 Gy, preferably at least 20 Gy, more preferably at least 40 Gy, and even more preferably at least 50 Gy.

[0050] According to a preferred embodiment of the invention, the PBMC is cultured for at least 4 h, preferably at least 6 h, and more preferably at least 12 h before separating its supernatant.

[0051] According to a preferred embodiment of the present invention, the PBMC cell culture contains 1×10 5 Up to 1×10 8 PBMCs / ml, preferably 1×10⁻⁶ 6 Up to 1×10 7 PBMCs / ml, more preferably 2×10 6 Up to 5×10 6 PBMC / ml.

[0052] It was found that if a certain amount of PBMCs were cultured per ml of cell culture medium, the composition of the supernatant obtained from culturing the PBMCs showed favorable properties.

[0053] To extend the shelf life of the supernatant obtained by the method according to the invention, the supernatant can be lyophilized. Methods for lyophilizing such preparations are well known to those skilled in the art. Before use, the lyophilized preparation can be contacted with water or an aqueous solution containing buffers, stabilizers, salts, etc.

[0054] Surprisingly, it has been found that using the Ringer's solution of the present invention, the method of the present invention can yield PBMC supernatants that exhibit properties similar to, identical to, or even better than supernatants obtained by culturing PBMCs in cell cultures commonly used for mammalian cell culture (e.g., CellGro, CellGro GMP DC, RPMI, DMEM, X-vivo, and Ultraculture for obtaining PBMC supernatants). These properties are measured using a potency assay as described in EP 3 729 079B1, preferably involving a potency assay measuring the amount of AP-1 promoter activity and / or phosphorylated HSP-27 as described therein.

[0055] A particularly preferred aspect of the invention relates to a method for culturing PBMCs, comprising the step of incubating the cells in a medium containing Ringer's solution or composed of Ringer's solution under an atmosphere containing less than 1% carbon dioxide. The medium may also contain lactate, preferably sodium lactate. After culturing, the supernatant of the PBMC culture may be separated from the cells or cell debris.

[0056] The supernatant obtained by culturing PBMCs using the method of this invention can be used for the treatment and prevention of many diseases and conditions. For example, these supernatants have shown beneficial effects in wound healing, in the treatment of effects caused by myocardial infarction or stroke, and in the treatment and prevention of allergies. The presence of insulin in the culture medium is beneficial not only to the cells to be cultured but also to the supernatant obtained from such cell cultures. Insulin is known to exhibit immunomodulatory effects and can affect keratinocytes, fibroblasts, and endothelial cells, thus playing a positive role in wound healing.

[0057] The present invention is further illustrated in the following embodiments and examples, but is not limited thereto.

[0058] Preferred embodiments of the present invention include:

[0059] 1. A method for culturing mammalian cells, comprising the step of incubating the mammalian cells in a culture medium containing at least one sodium salt, at least one potassium salt and at least one calcium salt under an atmosphere containing less than 1% carbon dioxide.

[0060] 2. The method according to embodiment 1, wherein the atmosphere contains less than 0.5%, preferably less than 0.2%, more preferably less than 0.1%, and even more preferably less than 0.05% carbon dioxide.

[0061] 3. The method according to embodiment 1 or 2, wherein the atmosphere contains oxygen and / or nitrogen.

[0062] 4. The method according to any one of embodiments 1 to 3, wherein the culture medium contains 50 to 200 mmol / L, preferably 100 to 150 mmol / L, more preferably 125 to 135 mmol / L, more preferably 130 to 132 mmol / L, and more preferably about 131 mmol / L of sodium ions.

[0063] 5. The method according to any one of embodiments 1 to 4, wherein at least one sodium salt is sodium chloride.

[0064] 6. The method according to any one of embodiments 1 to 5, wherein the culture medium contains 2 to 8 mmol / L, preferably 3 to 6 mmol / L, more preferably 4 to 6 mmol / L, more preferably 5 to 6 mmol / L, and more preferably about 5.36 mmol / L of potassium ions.

[0065] 7. The method according to any one of embodiments 1 to 6, wherein at least one potassium salt is potassium chloride.

[0066] 8. The method according to any one of embodiments 1 to 7, wherein the culture medium contains 0.5 to 3 mmol / L, preferably 1 to 2 mmol / L, more preferably 1.5 to 2 mmol / L, and more preferably about 1.84 mmol / L of calcium ions.

[0067] 9. The method according to any one of embodiments 1 to 8, wherein at least one calcium salt is calcium chloride.

[0068] 10. The method according to any one of embodiments 1 to 9, wherein the culture medium is Ringer's solution.

[0069] 11. The method according to any one of embodiments 1 to 10, wherein the culture medium further comprises at least one C2 to C5 carboxylate, wherein the C2 to C5 carboxylate is preferably a lactate, more preferably an L-lactate, and / or wherein at least one C2 to C5 carboxylate is an alkali metal salt or an alkaline earth metal salt, preferably a sodium salt.

[0070] 12. The method according to any one of embodiments 1 to 11, wherein the culture medium contains at least one polypeptide, preferably at least one blood polypeptide, more preferably at least one polypeptide selected from albumin, preferably serum albumin, and insulin.

[0071] 13. The method according to embodiment 12, wherein the culture medium contains at least one polypeptide of 1 mg / L to 50 g / L, preferably 2 mg / L to 40 g / L, more preferably 4 mg / L to 30 g / L, more preferably 1 g / L to 20 g / L, and more preferably 2 g / L to 10 g / L.

[0072] 14. The method according to any one of embodiments 1 to 13, wherein the culture medium comprises 1 to 50 g / L, preferably 2 to 40 g / L, more preferably 4 to 30 g / L, more preferably 5 to 20 g / L, more preferably 6 to 10 g / L of albumin (preferably serum albumin), and / or 1 to 20 mg / L, preferably 2 to 15 mg / L, more preferably 3 to 10 mg / L, more preferably 4 to 6 mg / L of insulin.

[0073] 15. The method according to any one of embodiments 1 to 14, wherein the cell is a peripheral blood mononuclear cell (PBMC), more preferably a monocyte, T cell, B cell and / or NK cell.

[0074] Example

[0075] Materials and Methods

[0076] Isolation of PBMCs and generation of the PBMC secretome

[0077] PBMCs were obtained by density gradient centrifugation assisted by Ficoll-Paque PLUS (GE Healthcare, USA) and then irradiated with 60 Gy of cesium-137 γ (IBL 437C, Isotopen Diagnostik CIS GmbH, Germany). The cells were then regulated to a size of 2.5 × 10⁻⁶. 7 Cells were cultured at a concentration of 100 cells / mL (equivalent to 25 U / mL) in different culture media outlined in Table 1 for 24 hours in an atmosphere containing approximately 5% CO2 or approximately 0.04% CO2 (atmospheric air). Cells and cell debris were removed by centrifugation, and the supernatant was passed through a 0.2 µm filter.

[0078] Table 1

[0079]

[0080] HSP27 phosphorylation assay

[0081] To detect phosphorylation of HSP27 at residue Ser82, A549 cells were treated for 30 minutes, fixed, and permeabilized. Phosphorylation was assessed by sequentially adding an antibody to detect phosphorylated HSP27, followed by peroxidase-conjugated anti-rabbit IgG antibody and chemiluminescent peroxidase substrate. Plate readings were performed using a luminescent plate reader. The relative titers of the analyzed samples were calculated relative to standards using PLA software. Detailed protocol details can be found in EP 3 729 079 B1. The results for the culture media are shown in Table 1. Figure 1 middle.

[0082] AP-1 reporter gene assay

[0083] Human neuroblastoma SH-SY5Y cells containing an integrated expression cassette encoding firefly luciferase under the transcriptional control of AP-1 were cultured in Ham's F12 / MEM (50:50) supplemented with 2 mM L-glutamine, 1× MEM non-essential amino acid solution, 15% fetal bovine serum and 1 μg / ml puromycin, or in DMEM / F12 + Glutamax supplemented with 10% fetal bovine serum and 1 μg / ml puromycin. To determine titer, SH-SY5Y AP-1 cells were seeded into 96-well plates (20,000 cells / well) and incubated overnight. After stimulation with supernatant, luciferase substrate was added to all wells, and the plates were read using a luminescent plate reader. Detailed protocol details can be found in EP 3 729 079 B1. Results for media 1 and 3 in Table 1 are shown below. Figure 2 middle.

[0084] Cytokine assay

[0085] As described by Laggner M et al. (Stem Cell Res Ther. 2020 Jan 3;11(1):9. doi: 10.1186 / s13287-019-1524-2), the concentrations of EGF and TGF β1 were measured by enzyme-linked immunosorbent assay (ELISA). The results for media 1 and 3 in Table 1 are shown below. Figure 3 and Figure 4 middle.

[0086] budding test

[0087] The angiogenic potential of the supernatant was functionally tested using a sprouting assay of mouse thoracic aorta embedded in a hydrogel (see Laggner M et al. (Stem Cell Res Ther. 2020 Jan 3;11(1):9. doi:10.1186 / s13287-019-1524-2)). Aortic rings were sandwiched between fibrin matrix and cultured at a secretomic concentration of 4 U / mL for five to seven days. The results for media 1 and 2 in Table 1 are shown below. Figure 5 middle.

[0088] Results Summary

[0089] The results obtained using the above measurements indicate that, under an atmosphere containing atmospheric carbon dioxide concentrations, the Ringer's solution-based medium yields similar or even better results compared to the medium typically used to obtain PBMC supernatant.

Claims

1. A method for culturing peripheral blood mononuclear cells (PBMCs), comprising the step of incubating the cells in Ringer's solution under an atmosphere containing less than 1% carbon dioxide.

2. The method according to claim 1, wherein the atmosphere contains less than 0.5%, preferably less than 0.2%, more preferably less than 0.1%, and even more preferably less than 0.05% carbon dioxide.

3. The method according to claim 1 or 2, wherein the atmosphere comprises oxygen and / or nitrogen.

4. The method according to any one of claims 1 to 3, wherein the Ringer's solution further comprises at least one C2 to C5 carboxylate, wherein the C2 to C5 carboxylate is preferably a lactate, more preferably an L-lactate, and / or wherein the at least one C2 to C5 carboxylate is an alkali metal salt or an alkaline earth metal salt, preferably a sodium salt.

5. The method according to any one of claims 1 to 4, wherein the Ringer's solution comprises at least one polypeptide, preferably at least one blood polypeptide, more preferably at least one polypeptide selected from albumin, preferably serum albumin, and insulin.

6. The method according to claim 5, wherein the Ringer's solution comprises 1 mg / L to 50 g / L, preferably 2 mg / L to 40 g / L, more preferably 4 mg / L to 30 g / L, more preferably 1 g / L to 20 g / L, and more preferably 2 g / L to 10 g / L of the at least one polypeptide.

7. The method according to any one of claims 1 to 6, wherein the Ringer's solution comprises 1 to 50 g / L, preferably 2 to 40 g / L, more preferably 4 to 30 g / L, more preferably 5 to 20 g / L, more preferably 6 to 10 g / L of albumin, wherein the albumin is preferably serum albumin, and / or 1 to 20 mg / L, preferably 2 to 15 mg / L, more preferably 3 to 10 mg / L, more preferably 4 to 6 mg / L of insulin.

8. The method according to any one of claims 1 to 7, wherein the peripheral blood mononuclear cells comprise monocytes, T cells, B cells and / or NK cells.

Citation Information

Patent Citations

  • Potency assay of secretomes

    EP3729079B1

  • Pharmaceutical preparation

    WO2010070105A1

  • Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture

    WO2010079086A1